Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Release of TFPI by Anticoagulants in Cancer Patients by Standard or LMW Heparin

NCT00004875 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Release of TFPI by Anticoagulants in Cancer Patients by Standard or LMW Heparin
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
July 31, 1996
Completion date
March 31, 1999
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, thromboembolism, unspecified adult solid tumor, protocol specific